Newer type 2 diabetes therapies continue to yield mixed safety reports. Along with concerns about pancreatitis and pancreatic cancer, a sub-class of incretin-based pills called DPP-4 drugs such as Ong...
In March, Johnson & Johnson lost its first DePuy Articular Surface Replacement (ASR) trial to the tune of $8.3 million. Not surprisingly, the device manufacturer continued to deny liability for defect...
Pharmaceutical forecasters say sales of blood thinners will grow higher than any other prescription drug class over the next six years, according to a new report. EvaluatePharma, a group that analyzes...
Statins prescribed to lower cholesterol may also be beneficial for reducing the risk of a number of other health problems, doctors say. They point to a new study, published in the July 2013 American H...
Medical device manufacturer Medtronic, which is already embroiled in litigation about a synthetic bone graft product it makes, also produced a pain pump linked to 14 deaths, according to Bloomberg. Th...
Several high-potency statins, a class of widely prescribed cholesterol-lowering drugs, may increase the risk for developing type 2 diabetes, according to a recent study published in the British Medica...
In response to a staggering decline in sales and a recent U.S. Food and Drug Administration (FDA) proposal to tighten regulations on all-metal hip implants, Johnson & Johnson has opted to halt the sal...
Thousands of American women fighting to get their voices heard and draw awareness to the life-changing complications of transvaginal mesh are not alone. The problems surrounding these controversial im...
Researchers in Japan have developed a new blood test that may hold promise for catching pancreatic cancer early enough to improve patient survival. That could be good news for diabetes patients, who m...
Hip implant recalls cost orthopaedic manufacturing companies Stryker and Johnson & Johnson millions of dollars so far in 2013, according to first-quarter earnings reports by the companies. Stryker Cor...
